OVARIAN ENDOMETRIOID TUMOR
Clinical trials for OVARIAN ENDOMETRIOID TUMOR explained in plain language.
Never miss a new study
Get alerted when new OVARIAN ENDOMETRIOID TUMOR trials appear
Sign up with your email to follow new studies for OVARIAN ENDOMETRIOID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo may offer alternative to chemo for ovarian cancer
Disease control OngoingThis study tested whether the targeted drugs olaparib (alone or with cediranib) work better than standard platinum-based chemo for women with ovarian, fallopian tube, or peritoneal cancer that came back after initial treatment. About 579 women with platinum-sensitive cancer took …
Matched conditions: OVARIAN ENDOMETRIOID TUMOR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 04:34 UTC
-
New drug combo shows promise for recurrent ovarian cancer in early trial
Disease control OngoingThis early-phase trial tests whether adding an experimental drug (berzosertib) to standard chemotherapy (carboplatin and gemcitabine) is safe and effective for people with ovarian, peritoneal, or fallopian tube cancer that has returned and spread. The study involves 35 participan…
Matched conditions: OVARIAN ENDOMETRIOID TUMOR
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:53 UTC